Rhythm Pharmaceuticals, Inc.
Pharmaceutical & medical device company payment data from CMS Open Payments.
Total Payments
$22.4M
Doctors Paid
2,199
Transactions
9,418
2024 Total
$8.0M
Payment Breakdown by Category
Research$21.6M (96.3%)
Food & Beverage$142,510 (0.6%)
Consulting$87,088 (0.4%)
Travel$72,980 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $21.6M | 4,980 | 96.3% |
| Honoraria | $503,401 | 366 | 2.2% |
| Food and Beverage | $142,510 | 3,742 | 0.6% |
| Consulting Fee | $87,088 | 54 | 0.4% |
| Travel and Lodging | $72,980 | 197 | 0.3% |
| Grant | $20,000 | 1 | 0.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $3,503 | 2 | 0.0% |
| Compensation for serving as faculty or as a speaker for a medical education program | $3,187 | 1 | 0.0% |
| Education | $3,173 | 75 | 0.0% |
Payments by Type
Research
$21.6M
4,980 transactions
General
$835,841
4,438 transactions
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| A Trial of Setmelanotide in Acquired Hypothalamic Obesity | $3.4M | 0 | 121 |
| RM-493-034 | $3.0M | 0 | 1,242 |
| EMANATE: A Study of Setmelanotide in Patients With Specific Gene Variants in the MC4R Pathway | $2.5M | 0 | 1,394 |
| RM-493-035 | $2.4M | 0 | 894 |
| RM-493-014 | $2.3M | 0 | 188 |
| RM-493-022 | $2.0M | 0 | 191 |
| DAYBREAK: A Study of Setmelanotide in Patients With Specific Gene Variants in the MC4R Pathway | $993,142 | 0 | 527 |
| RHYTH001_RM 493-040_80072978 | $768,484 | 0 | 42 |
| Long Term Extension Trial of Setmelanotide | $712,574 | 0 | 92 |
| RM-493-030 | $652,003 | 0 | 24 |
| RM-493-037/RM-493-022/RM-493-033 | $402,548 | 0 | 2 |
| RM-493-023 | $394,051 | 0 | 35 |
| RM-493-029 | $359,586 | 0 | 13 |
| RM-493-037/RM-493-022 | $245,882 | 0 | 1 |
| RM-493-014/RM-493-022 | $212,491 | 0 | 6 |
| RM-493-022/ RM-493-014 | $202,835 | 0 | 7 |
| RM-493-033 | $194,556 | 0 | 29 |
| RM-493-037 | $140,511 | 0 | 15 |
| A Study to Assess Efficacy and Safety of LB54640 in Patients With Hypothalamic Obesity | $140,328 | 0 | 25 |
| RM-493-037/RM-493-033/RM-493-022 | $122,313 | 0 | 2 |
| RM-493-013 | $91,949 | 0 | 35 |
| RM-493-033/RM-493-022 | $83,888 | 0 | 2 |
| Setmelanotide in Pediatric Patients With Rare Genetic Diseases of Obesity | $76,293 | 0 | 19 |
| RM-493-023/RM-493-014 | $30,897 | 0 | 1 |
| RM-493-030/RM-493-022 | $30,469 | 0 | 2 |
| Phase 3 Crossover Trial of Two Formulations of Setmelanotide in Patients With Specific Gene Defects in the MC4R Pathway | $30,331 | 0 | 3 |
| RM-493-037/RM-493-033 | $27,606 | 0 | 3 |
| RM-493-033/RM-493-037 | $25,036 | 0 | 1 |
| RM-493-030/ RM-493-022 | $16,610 | 0 | 1 |
| RM-493-014/RM-493-022/RM-493-037 | $13,012 | 0 | 1 |
Payments by Medical Specialty
Top Paid Doctors — Page 85
| Doctor | Specialty | Location | Total | 2024 |
|---|---|---|---|---|
| Hector Lopez, Md, MD | Family Medicine | Greenfield, WI | $14.63 | $0 |
| Dr. Toni Johnson-Chavis, M.d, M.D | Pediatrics | Compton, CA | $14.61 | $0 |
| Christopher Albergo, M.d, M.D | Endocrinology, Diabetes & Metabolism | Murfreesboro, TN | $14.61 | $0 |
| Mary Fulghum, Np, NP | Family | Murfreesboro, TN | $14.61 | $0 |
| Benito Lopez, Pa-C, PA-C | Medical | Edinburg, TX | $14.58 | $0 |
| Pamela Lopez, Aprn-Bc, Cde, APRN-BC, CDE | Family | Weslaco, TX | $14.58 | $0 |
| Elizabeth Haglind, Md, MD | Endocrinology, Diabetes & Metabolism | Edina, MN | $14.55 | $0 |
| Bradley Hise, Fnp, FNP | Registered Nurse | Edina, MN | $14.55 | $0 |
| Rebecca Mattison, Md, MD | Specialist | Edina, MN | $14.54 | $0 |
| John Chow, M.d, M.D | Endocrinology, Diabetes & Metabolism | Edina, MN | $14.54 | $0 |
| Desiree Rivera-Nieves, M.d, M.D | Pediatric Gastroenterology | Sarasota, FL | $14.51 | $0 |
| Shirley Chan-Ramirez, Md, MD | Pediatrics | Bellaire, TX | $14.41 | $0 |
| Julie Mallers | Family | Crown Point, IN | $14.41 | $0 |
| Lisa Mullally, D.o, D.O | Family Medicine | Crown Point, IN | $14.40 | $0 |
| Sascha Dougan, Np, NP | Family | Morristown, NJ | $14.38 | $0 |
| Julie Wilson, Aprn, APRN | Nurse Practitioner | Florence, KY | $14.32 | $0 |
| Brandi Haerer, Np, NP | Nurse Practitioner | Columbia, MO | $14.19 | $0 |
| Timur Gusov, Md, MD | Internal Medicine | Milwaukee, WI | $14.18 | $0 |
| Dr. Phillip Beck, M.d, M.D | Infectious Disease | Columbia, MO | $14.18 | $0 |
| Dr. Asjad Khan, Md, MD | Pediatrics | Port Charlotte, FL | $14.15 | $0 |
| Sheresa Campbell, Aprn, APRN | Neonatal | Fort Myers, FL | $14.15 | $0 |
| Aslam Qureshi | Pediatric Nephrology | Port Charlotte, FL | $14.14 | $0 |
| Tammy Mccarty, Aprn, APRN | Clinical Nurse Specialist | Fort Myers, FL | $14.14 | $0 |
| Irina Gershin-Stevens, Do, DO | Pediatric Nephrology | Port Charlotte, FL | $14.14 | $0 |
| Dr. Sujana Reddy, M.d, M.D | Pediatric Endocrinology | Port Charlotte, FL | $14.14 | $0 |
About Rhythm Pharmaceuticals, Inc.
Rhythm Pharmaceuticals, Inc. has made $22.4M in payments to 2,199 healthcare providers, recorded across 9,418 transactions in the CMS Open Payments database. In 2024, the company paid $8.0M. The top product by payment volume is Imcivree ($14.1M).
Payments were distributed across 102 medical specialties. The top specialty by payment amount is Pediatric Endocrinology ($144,689 to 140 doctors).
Payment categories include: Food & Beverage ($142,510), Consulting ($87,088), Research ($21.6M), Travel & Lodging ($72,980).
Rhythm Pharmaceuticals, Inc. is associated with 3 products in the CMS Open Payments database.